Filing Details
- Accession Number:
- 0001209191-21-020210
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-12 16:53:56
- Reporting Period:
- 2021-03-11
- Accepted Time:
- 2021-03-12 16:53:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1490978 | Schrodinger Inc. | SDGR | Pharmaceutical Preparations (2834) | 954284541 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1798426 | Richard Friesner | C/O Schrodinger, Inc., 120 West 45Th Street, 17Th Floor New York NY 10036 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-03-11 | 12,000 | $80.28 | 504,450 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-11 | 20,000 | $80.46 | 694,925 | No | 4 | S | Indirect | By grantor retained annuity trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Indirect | By grantor retained annuity trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 28,328 | Indirect | By Spouse |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2020
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $80.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (3).
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $80.96, inclusive.
- These shares are owned directly by the RF 2018 GRAT (the "Trust"), a grantor retained annuity trust, and indirectly by Mr. Friesner as trustee and sole annuitant of the Trust.